Back to Search
Start Over
Entrada Therapeutics to Collaborate With Vertex Pharmaceuticals on EEV-Therapeutics, for $250 Million in Equity and Upfront Payments, Up to $485 Million in Milestone Payments, and Royalties
- Source :
- European Union News. December 12, 2022
- Publication Year :
- 2022
-
Abstract
- Boston, Massachusetts: Goodwin Procter LLP has issued the following press release: The Life Sciences team advised Entrada Therapeutics, Inc. (Nasdaq: TRDA) on its global collaboration with Vertex Pharmaceuticals Incorporated (Nasdaq: [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- European Union News
- Publication Type :
- News
- Accession number :
- edsgcl.729774496